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ABSTRACT
Background
Toll-like receptors (TLRs) are essential in host defense against pathogens by virtue of their
capacity to detect microbes and initiate the immune response. TLR2 is seen as the most
important receptor for gram-positive bacteria, while TLR4 is regarded as the gram-negative
TLR. Melioidosis is a severe infection caused by the gram-negative bacterium, Burkholderia
pseudomallei, that is endemic in Southeast Asia. We aimed to characterize the expression and
function of TLRs in septic melioidosis.
Methods and Findings
Patient studies: 34 patients with melioidosis demonstrated increased expression of CD14,
TLR1, TLR2, and TLR4 on the cell surfaces of monocytes and granulocytes, and increased CD14,
TLR1, TLR2, TLR4, LY96 (also known as MD-2), TLR5, and TLR10 mRNA levels in purified
monocytes and granulocytes when compared with healthy controls. In vitro experiments:
Whole-blood and alveolar macrophages obtained from TLR2 and TLR4 knockout (KO) mice
were less responsive to B. pseudomallei in vitro, whereas in the reverse experiment, transfection
of HEK293 cells with either TLR2 or TLR4 rendered these cells responsive to this bacterium. In
addition, the lipopolysaccharide (LPS) of B. pseudomallei signals through TLR2 and not through
TLR4. Mouse studies: Surprisingly, TLR4 KO mice were indistinguishable from wild-type mice
with respect to bacterial outgrowth and survival in experimentally induced melioidosis. In
contrast, TLR2 KO mice displayed a markedly improved host defenses as reflected by a strong
survival advantage together with decreased bacterial loads, reduced lung inflammation, and
less distant-organ injury.
Conclusions
Patients with melioidosis displayed an up-regulation of multiple TLRs in peripheral blood
monocytes and granulocytes. Although both TLR2 and TLR4 contribute to cellular
responsiveness to B. pseudomallei in vitro, TLR2 detects the LPS of B. pseudomallei, and only
TLR2 impacts on the immune response of the intact host in vivo. Inhibition of TLR2 may be a
novel treatment strategy in melioidosis.
The Editors’ Summary of this article follows the references.
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PLoS MEDICINEIntroduction
The recently discovered family of Toll-like receptors
(TLRs), which are conserved across many species, has
emerged as an important ﬁrst line of defense against invading
pathogens. They detect host invasion by pathogens, initiate
immune responses, and form the crucial link between the
innate and adaptive immune systems [1,2]. Upon the ﬁrst
encounter with a pathogen, TLRs recognize conserved motifs
termed pathogen-associated molecular patterns (PAMPs)
[1,2]. In general, the immune activation that follows the
interaction between TLRs and PAMPs is sufﬁcient to
eliminate the wide variety of pathogens that daily invade
the human body. However, in the case of sepsis, these TLR-
mediated inﬂammatory responses may exceed the threshold
below which immune system homeostasis is maintained and
thereby cause harm.
In Southeast Asia and northern Australia the gram-
negative soil-dwelling bacillus Burkholderia pseudomallei is an
important cause of community-acquired sepsis and sepsis-
related mortality [3,4]. More than half of the cases of
melioidosis, as this severe infection is named, commonly
presents with pneumonia with bacterial dissemination to
distant sites [5]. The mortality of primary disease is 50% in
northeast Thailand and around 20% in the higher-technology
setting of northern Australia [6,7]. Reported cases are likely
to represent ‘‘the tip of the iceberg,’’ since conﬁrmation of
disease depends on bacterial isolation, a technique that is not
available in large areas of the world [3,8]. Interest in disease
pathogenesis of B. pseudomallei has increased following its
classiﬁcation as a category B disease/agent of bioterrorism by
the US Centers for Disease Control and Prevention (http://
www.bt.cdc.gov/agent/agentlist.asp).
It is likely that TLRs contribute to host defense against B.
pseudomallei. In general, TLR4 is considered of utmost
importance for host defense against gram-negative infection
by virtue of its capacity to sense lipopolysaccharide (LPS)
present in the outer membrane of gram-negative bacteria
and to relay LPS effects into the cellular interior [9]. Besides
TLR4, TLR2 may play a role in the host response to B.
pseudomallei, given that this bacterium expresses several
PAMPs that can interact with TLR2, including lipopeptides
and peptidoglycan. However, these assumptions remain
speculative since the expression and function of these TLRs
have not been studied in melioidosis thus far.
In the present study we aimed to characterize the
expression and function of TLRs in sepsis caused by B.
pseudomallei and found that, although both TLR2 and TLR4
contribute to cellular responsiveness to B. pseudomallei in
vitro, only TLR2 impacts on the immune response of the
intact host in vivo.
Methods
Human Studies
Patients. Blood samples were taken from 34 patients with
sepsis caused by B. pseudomallei. Patients were prospectively
recruited over a 4 mo period after admission to Sapprasithi-
prasong Hospital, a 1,000-bed government hospital located in
Ubon Ratchathani, northeast Thailand. Sepsis caused by
melioidosis was deﬁned by the presence of (1) culture-proven
infection with B. pseudomallei and (2) systemic inﬂammatory
response syndrome (SIRS) as indicated by three or more of
the following criteria: a core temperature of   38 8Co r  36
8C; a heart rate of   90 beats/min; a respiratory rate of   20
breaths/min or a PaCO2 of   32 mm Hg or the use of
mechanical ventilation for an acute respiratory process; a
white-cell count of   12310
9/l or   4310
9/l or a differential
count showing . 10% immature neutrophils [10]. Exclusion
criteria were the use of dialysis and/or immunosuppressive
therapy, known disorders of coagulation, and concomitant
infection with HIV. Blood samples were drawn within 36 h
after start of antimicrobial therapy. When possible, an
additional blood sample was drawn from patients who
recovered after 2 wk of treatment. 32 healthy individuals,
who were recruited from the Sapprasithiprasong Hospital
blood bank as blood donors, served as a control population.
The study was approved by both the Ministry of Public
Health, Royal Government of Thailand and the Oxford
Tropical Research Ethics Committee, University of Oxford,
England and written informed consent was obtained from all
study participants or their attending relatives.
RNA analysis using multiplex ligation-dependent probe
ampliﬁcation. Heparinized blood samples were drawn from
the antecubital vein and immediately put on ice. Leukocytes
were isolated using erythrocyte lysis buffer. Monocyte- and
granulocyte-enriched populations were isolated using Poly-
morphprep (Axis-Shield, http://www.axis-shield.com/). Mono-
cyte and granulocyte fractions were . 98% pure as
determined by their scatter pattern on ﬂow cytometry. After
isolation leukocytes, monocytes, and granulocytes were
dissolved in Trizol (Invitrogen, http://www.invitrogen.com/)
and stored at  80 8C until used for RNA isolation. RNA was
isolated and analyzed by multiplex ligation-dependent probe
ampliﬁcation (MLPA) as described [11–14] using a TLR-
speciﬁc kit developed in collaboration with MRC-Holland
(http://www.mlpa.com/) for the simultaneous detection of 17
mRNA molecules; four different probe sets were generated
for TLR4 corresponding with four different TLR4 splice
variants (R01 to R04) identiﬁed in the National Center for
Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.
gov); similarly, two different probe sets for TLR8 were
generated corresponding with two different TLR8 splice
variants (R01 and R02). We recently published the speciﬁc
oligonucleotides used for all TLR probe sets [15]. All samples
were tested with the same batch of reagents. The levels of
mRNA for each gene were expressed as a normalized ratio of
t h ep e a ka r e ad i v i d e db yt h ep e a ka r e ao ft h ebeta-2
microglobulin (B2M) gene, resulting in the relative abundance
of mRNAs of the genes of interest [11–14].
FACS analysis. CD14 and TLR cell surface expression on
peripheral monocytes and granulocytes was determined by
ﬂow cytometry using ﬂuorochrome-conjugated mouse anti-
humanCD14(BDBiosciences,http://www.bdbiosciences.com/),
TLR1, TLR2, and TLR4 (all eBioscience, http://www.
ebioscience.com/) antibodies in accordance with the manu-
facturer’s recommendations. Granulocytes were deﬁned ac-
cording to their scatter pattern and monocytes according to
their scatter pattern and CD14 positivity. To correct for
nonspeciﬁc staining, appropriate isotype control antibodies
(BD Biosciences) were used. Samples were analyzed directly
after sample collection by ﬂow cytometry using FACScan (BD
Biosciences).
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Mice. Pathogen-free 8- to 10-wk-old wild-type (WT) C57BL/
6 mice were purchased from Harlan Sprague Dawley (http://
www.harlan.com/). TLR2 knockout (KO) mice [16] and TLR4
KO mice [17] backcrossed six times to a C57BL/6 background
were generously provided by Dr. Shizuo Akira, Osaka
University, Japan. Age- and sex-matched animals were used
in all experiments. The Animal Care and Use of Committee of
the University of Amsterdam approved all experiments.
Preparation of alveolar macrophages. Alveolar macro-
phages were harvested from TLR2 KO, TLR4 KO, and WT
mice by bronchoalveolar lavage (n ¼ 5–8 per strain) as
described [18,19].The trachea was exposed through a midline
incision and cannulated with a sterile 22-gauge Abbocath-T
catheter (Abbott, http://www.abbott.ie/). Bronchoalveolar lav-
age was performed by instilling three 0.5 ml aliquots of sterile
saline. Total cell numbers were counted from each sample
using a hemacytometer. Cells were resuspended in RPMI 1640
containing 1 mM pyruvate, 2 mM L-glutamine, penicillin/
streptomycin (100 units penicillin, 100 g streptomycin), and
10% FCS in a ﬁnal concentration of 1310
4 cells/100 ll. Cells
were then cultured in 96-well microtiter plates (Greiner,
http://www.greinerbioone.com/) for 2 h and washed with RPMI
1640 to remove nonadherent cells. Adherent monolayer cells
were stimulated with washed (three times in normal saline),
heat-killed B. pseudomallei (clinical isolate strain 1026b [20,21];
1 3 10
5 colony-forming units (CFU)/ml) or RPMI 1640 for 16
h. Supernatants were collected and stored at  20 8C until
assayed for tumor necrosis factor a (TNFa).
LPS extraction from B. pseudomallei 1026. LPS was extracted
from B. pseudomallei 1026b [22]. Bacteria from frozen stock
were inoculated into 5 ml of LB broth and incubated
overnight at 37 8C in air with shaking at 200 rpm. This
starting culture was streaked onto 50 LB agar plates per
strain. Plates were incubated at 37 8C in air for 2 d, after
which bacterial colonies were scraped from plates and
resuspended in 100 ml of sterile distilled water. LPS
extraction using a hot aqueous-phenol method was per-
formed as described by Brett et al. [23]. Puriﬁed B. pseudomallei
LPS was characterized by SDS-PAGE and silver staining [24].
HEK cells. Human embryonic kidney (HEK) 293 cells stably
expressing CD14, CD14 TLR4, or CD14 TLR2, kindly pro-
vided by Dr. Douglas Golenbock, University of Massachusetts
Medical School, Worcester, Massachusetts, have been de-
scribed [25,26]. Cells were stimulated with LPS from B.
pseudomallei 1026b (100 ng/ml), heat-killed B. pseudomallei (5 3
10
7 CFU/ml), or RPMI for 6 h. Supernatants were harvested
and stored at  20 8C until assayed for interleukin (IL) 8.
Experimental infection. For preparation of the inoculum,
B. pseudomallei strain 1026b was used (this strain was isolated
in Sappasithiprasong Hospital in 1993 from a blood culture
from a septic 29-y-old female rice farmer, who presented with
bacteremia with soft tissue, skin, joint, and spleen involve-
ment [20,21]). Stock bacteria were streaked from frozen
aliquots into 50 ml Luria broth (Difco) for overnight
incubation at 37 8C in a 5% CO2 incubator. Thereafter, a 1
ml portion was transferred to fresh Luria broth and grown
for approximately 5 h to midlogarithmic phase. Bacteria were
harvested by centrifugation at 1500g for 15 min, washed, and
resuspended in sterile isotonic saline at a concentration of 5
3 10
2 CFU/50 ll, as determined by plating serial 10-fold
dilutions on blood agar plates. Pneumonia was induced by
intranasally inoculating mice with 50 ll( 53 10
2 CFU) of
bacterial suspension. For this procedure, mice were lightly
anesthetized by inhalation of isoﬂuorane (Upjohn).
Determination of bacterial outgrowth. At 24, 48, and 72 h
after infection, mice were anesthetized with Hypnorm
(Janssen Pharmaceutica, http://www.janssenpharmaceutica.
be/; active ingredients, fentanyl citrate and ﬂuanisone) and
midazolam (Roche, http://www.roche.com/) and sacriﬁced by
bleeding from the inferior vena cava. The lungs and spleens
were harvested and homogenized at 4 8C in four volumes of
sterile saline using a tissue homogenizer (Biospec Products,
http://www.biospec.com/). CFUs were determined from serial
dilutions of organ homogenates and blood, plated on blood
agar plates and incubated at 37 8Ca t5 %C O 2 for 16 h before
colonies were counted.
Preparation of lung tissue for cytokine measurements. For
cytokine measurements, lung homogenates were diluted 1:2
in lysis buffer containing 300 mM NaCl, 30 mM Tris (pH 7.4),
2 mM MgCl2, 2 mM CaCl2, 1% Triton X-100, and pepstatin A,
leupeptin, and aprotinin (all 20 ng/ml) and incubated at 4 8C
for 30 min. Homogenates were centrifuged at 1,500g at 4 8C
for 15 min, and supernatants were stored at  20 8C until
assays were performed.
Assays. Human IL8 was measured by ELISA (Biosource,
http://www.biosource.com/). Mouse TNFa, IL6, and IL10 were
measured by cytometric bead array multiplex assay (BD
Biosciences) in accordance with the manufacturer’s recom-
mendations. Aspartate aminotransferase (ASAT) and alanine
aminotransferase (ALAT) were determined with commer-
cially available kits (Sigma-Aldrich, http://www.sigmaaldrich.
com), using a Hitachi analyzer (Roche) according to the
manufacturer’s instructions. Immunostaining for TLR4 on
blood cells and whole lung-cell suspensions was performed
using directly labeled antibodies against GR-1 (GR-1 FITC;
Pharmingen) and TLR4 (TLR4-AlexaFluor, all Bioscience)
and a biotin-labeled antibody against F4/80 (Serotec, http://
www.ab-direct.com/) in combination with streptavidin allo-
phycocyanine. All antibodies were used in concentrations
recommended by the manufacturer. After staining, cells were
ﬁxed in 2% paraformaldehyde. TLR4 mean ﬂuorescence
intensity (MFI) was measured in the Gr-1-high gate (gran-
ulocytes), sidescatter low and F4/80 positive (monocytes), and
sidescatter high and F4/80 positive (macrophages) gated
populations.
Pathology. Lungs and spleens for histology were harvested
after infection, ﬁxed in 10% formalin and embedded in
parafﬁn. Sections of 4 lm were stained with hematoxylin–
eosin, and analyzed by a pathologist who was blinded as to
groups. To score lung inﬂammation and damage, the entire
lung surface was analyzed with respect to the following
parameters: surface with pneumonia, necrosis and/or for-
mation of abscess, interstitial inﬂammation, endothelialitis,
bronchitis, edema, thrombus formation, and pleuritis. Each
parameter was graded on a scale of 0 to 4: 0, absent; 1, mild; 2,
moderate; 3, severe; and 4, very severe. The total ‘‘lung
inﬂammation score’’ was expressed as the sum of the scores
for each parameter, the maximum being 32. Spleen sections
were scored on inﬂammation, necrosis/abscess formation, and
thrombus formation using the scale given above. The
maximum total spleen inﬂammation score was 12. Granulo-
cyte staining was done exactly as described previously [27,28].
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TLRs in MelioidosisStatistical Analysis
Values are expressed as mean 6 standard error of the
mean (SEM). Differences between groups were analyzed by
Mann-Whitney U test or Kruskal-Wallis analysis with Dunn
post hoc test where appropriate. For survival analysis,
Kaplan-Meier analysis followed by log-rank test was per-
formed. These analyses were performed using GraphPad
Prism version 4.00, GraphPad Software (http://www.graphpad.
com/). Values of p , 0.05 were considered statistically
signiﬁcant.
Results
Patient Characteristics
A total of 34 patients with sepsis caused by B. pseudomallei
(mean age 52 y, range 18–86 y; 50% male) and 32 healthy
control participants (mean age 41 y, range 21–59 y; 71%
male) were enrolled. B. pseudomallei was cultured from body
material from all patients: blood cultures were positive for B.
pseudomallei in 21 patients (61.7%), throat swab or tracheal
suction in 13 patients (38.0%), sputum in seven patients
(21.0%), pus from abscesses in seven patients (21.0%), and
urine in ﬁve patients (14.7%). The overall patient mortality
was 44%.
Increased CD14, LY96 (MD-2), TLR1, TLR2, TLR3, TLR4, TLR5,
TLR8, and TLR10 mRNA Levels in Peripheral Blood Cells of
Patients with Septic Melioidosis
To obtain a ﬁrst insight into TLR gene expression during
melioidosis, we quantiﬁed TLR mRNAs in blood leukocytes
harvested from patients with septic melioidosis and healthy
controls. MLPA was performed on RNA isolated from whole
blood leukocytes as well as from monocyte- and granulocyte-
enriched (. 98% pure) populations. Patients with melioidosis
displayed elevated mRNA levels for most TLRs and TLR-
related proteins in unfractionated leukocytes, monocytes,
and granulocytes (Table 1; data of unfractionated leukocytes
not shown). Speciﬁcally, melioidosis was associated with
enhanced expression of monocyte and granulocyte mRNAs
encoding TLR1, TLR2, TLR4 (R01 and R04), TLR5, TLR8
(R01 and R02), and the TLR4 co-receptors LY96 (previously
known as MD-2) and CD14. Of note, TLR10 mRNA was up-
regulated only in unfractionated leukocytes (unpublished
data) and granulocytes, but not in monocytes (Table 1). The
mRNAs encoding TLR3, TLR7 (both similar in patients and
controls), and TLR9 (undetectable in patients and controls)
were not inﬂuenced by melioidosis.
Increased Expression of CD14, TLR1, TLR2, and TLR4 on
the Cell Surfaces of Circulating Monocytes and
Granulocytes of Patients with Septic Melioidosis
To determine the effect of B. pseudomallei sepsis on TLR
protein expression at the surface of peripheral blood cells, we
compared the expression of CD14, TLR1, TLR2, and TLR4 on
circulating monocytes and granulocytes of patients with
melioidosis and healthy controls using FACS analysis.
Relative to controls, patients displayed higher cell-associated
levels of CD14, TLR1, TLR2, and TLR4 on both monocytes
and granulocytes (Figure 1A). In addition, in ﬁve patients
from whom blood could be obtained after recovery (14 d after
admission), monocyte expression of CD14, TLR2, and TLR4
decreased during follow-up, whereas TLR1 levels did not
change in a consistent way (Figure 1B).
TLR2 and TLR4 Contribute to Cellular Responsiveness to B.
pseudomallei In Vitro
Having established that in particular TLR2 and TLR4
become up-regulated at the surface of blood leukocytes in
patients with severe melioidosis, we sought to obtain insights
into the function of these TLRs in melioidosis by testing the
requirement of TLR2 and TLR4 signaling upon ﬁrst
encounter between the bacterium and the host. We ﬁrst
Table 1. Toll-Like Receptor mRNA Expression in Peripheral Blood Monocytes and Granulocytes of Patients with Septic Melioidosis (n¼
34) and Healthy Controls (n ¼ 32)
Gene Monocytes Granulocytes
Controls Patients p-Value Controls Patients p-Value
TLR1 1.49 6 0.13 2.77 6 0.36 ,0.05 2.77 6 0.36 4.05 6 0.42 ,0.01
TLR2 0.09 6 0.01 0.70 6 0.25 ,0.001 0.55 6 0.42 0.70 6 0.18 ,0.001
TLR3 0.01 6 0.00 0.04 6 0.04 0.33 0.06 6 0.04 0.06 6 0.03 0.72
TLR4-R01 0.92 6 0.08 1.98 6 0.27 ,0.001 1.04 6 0.13 2.18 6 0.29 ,0.001
TLR4-R02 ND ND - ND ND -
TLR4-R03 0.77 6 0.06 1.38 6 0.15 0.24 1.20 6 0.14 1.84 6 0.22 ,0.05
TLR4-R04 0.28 6 0.02 0.79 6 0.11 ,0.001 0.53 6 0.21 1.08 6 0.18 ,0.001
TLR5 0.08 6 0.01 0.35 6 0.06 ,0.001 0.02 6 0.01 0.43 6 0.07 ,0.001
TLR7 0.42 6 0.04 0.38 6 0.05 0.39 0.06 6 0.02 0.05 6 0.02 0.27
TLR8-R01 0.20 6 0.08 0.64 6 0.12 ,0.001 0.24 6 0.03 0.55 6 0.08 ,0.001
TLR8-R02 1.87 6 0.12 4.42 6 0.64 ,0.001 2.43 6 0.27 5.05 6 0.66 ,0.001
TLR9 ND ND - ND ND -
TLR10 0.26 6 0.03 0.25 6 0.04 0.39 0.21 6 0.04 0.44 6 0.06 ,0.01
LY96 (MD-2) 1.31 6 0.10 2.86 6 0.40 ,0.001 2.32 6 0.23 4.22 6 0.46 ,0.001
CD14 2.31 6 0.15 5.19 6 0.62 ,0.001 2.46 6 1.14 4.28 6 0.52 ,0.001
mRNA levels (means 6 SEM) for each gene are expressed as a normalized ratio of the peak area divided by the peak area of the b2 microglobulin gene, resulting in the relative abundance
of mRNAs of the genes of interest [11–14].
ND: not detectable.
doi:10.1371/journal.pmed.0040248.t001
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TLRs in MelioidosisFigure 1. Increased Expression of CD14, TLR1, TLR2, and TLR4 on Peripheral Blood Monocytes and Granulocytes of Patients with Melioidosis
(A) Increased expression of CD14, TLR1, TLR2, and TLR4 on peripheral blood monocytes and granulocytes of patients with severe melioidosis (triangles;
n ¼ 34) and healthy controls (squares; n ¼ 32). Horizontal lines indicate median MFI.
(B). Patients (n¼5) who survived after 2 wk of intensive treatment showed normalization of CD14, TLR2, and TLR4, but not of TLR1 expression on the
cell surface of monocytes at discharge.
ns, not significant. *p , 0.05; **p , 0.01; ***p , 0.001.
doi:10.1371/journal.pmed.0040248.g001
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TLRs in Melioidosistested the capacity of alveolar macrophages and whole blood
harvested from WT, TLR2 KO, or TLR4 KO mice to release
TNFa upon stimulation with heat-killed B. pseudomallei
(effector:target ratio 1:10). Whole blood and alveolar macro-
phages obtained from TLR2 KO or TLR4 KO mice released
less TNFa than did alveolar macrophages and blood from WT
mice upon stimulation with B. pseudomallei in vitro (Figure 2A
and 2B). Consistent with these KO data, HEK293 cells stably
transfected with either CD14/TLR2 or CD14/TLR4 responded
to B. pseudomallei as reﬂected by a 103to 1003increase in the
release of IL8 into the supernatant (Figure 2C). These data
suggest that both TLR2 and TLR4 contribute to cellular
responsiveness to B. pseudomallei in vitro.
The LPS of B. pseudomallei Signals through TLR2
LPS has been implicated as playing a major role in the
induction of an innate immune response to gram-negative
bacteria. Although TLR4 is considered the LPS receptor, LPS
derived from some bacteria are recognized by TLR2. We
therefore were interested to determine whether LPS from B.
pseudomallei is recognized by TLR2 or TLR4. Remarkably,
using HEK293 cells stably transfected with either CD14/TLR2
or CD14/TLR4, we found that puriﬁed LPS of B. pseudomallei
1026b signals through TLR2 and not through TLR4 (Figure
2C).
TLR2 KO Mice, but Not TLR4 KO Mice, Are Protected from
B. pseudomallei-Induced Death
Having established that TLR2 and TLR4 take part in the
recognition of B. pseudomallei by immune cells in vitro, we
next investigated the involvement of these receptors in the
outcome of melioidosis. TLR2 KO, TLR4 KO, and WT mice
were intranasally infected with B. pseudomallei and followed
for 6 wk. All WT and TLR4 KO mice died within 5 d after
inoculation. However, mortality was delayed and reduced
among TLR2 KO mice, of which 40% survived until the end
of the 6 wk observation period (p , 0.0001 for the differences
between both mouse strains; Figure 3).
Figure 2. TLR2 and TLR4 Contribute to Cellular Responsiveness to B. pseudomallei In Vitro
(A and B) Freshly isolated alveolar macrophages (A) and whole blood (B) of WT, TLR2 KO, and TLR4 KO mice (n¼8 per group) were incubated with RPMI
1640 (control) or heat-killed B. pseudomallei (equivalent 10
5 CFU; target:effector ratio 1:10) for 16 h before TNFa production was measured.
(C) HEK293 cells stably transfected with CD14, CD14/TLR2, or CD14/TLR4 were incubated for 6 h with medium, LPS of B. pseudomallei 1026, or heat-
killed B. pseudomallei before measurement of IL8 in the supernatant.
Data are mean 6 SEM (n ¼ 4). ***p , 0.001.
doi:10.1371/journal.pmed.0040248.g002
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TLRs in MelioidosisTLR2 KO Mice, but Not TLR4 KO Mice, Show Reduced
Growth of B. pseudomallei In Vivo
To obtain insight into the mechanisms underlying the
reduced mortality of TLR2 KO mice during experimental
melioidosis, we infected WT, TLR2 KO, and TLR4 KO mice
with B. pseudomallei and sacriﬁced the mice after 24, 48, and 72
h (i.e., directly before the ﬁrst predicted death in WT mice) to
determine bacterial loads in lungs (the primary site of the
infection), blood, and spleen (to evaluate extent of bacterial
dissemination) (Figure 4). Relative to WT mice, TLR2 KO
mice displayed strongly reduced bacterial loads in lungs,
blood, and spleen at 72 h; this was also observed at the 48 h
time point, although the difference did not reach statistical
signiﬁcance. In TLR2 KO mice that survived 6 wk after
inoculation almost all bacteria were effectively cleared
(unpublished data). TLR4 KO mice demonstrated higher
bacterial loads only in spleen (p , 0.001) and blood (p , 0.05)
at 24 h after infection; however, at later time points bacterial
burdens did not differ signiﬁcantly in TLR4 KO and WT mice
in all body compartments except for the spleen at 72 h,
revealing modestly fewer B. pseudomallei CFU in TLR4 KO
mice (p , 0.001). Together, these data suggest that TLR4 may
play a minor role in limiting the early dissemination of B.
pseudomallei from the lungs and, more strikingly, that the
presence of TLR2 facilitates the growth of this pathogen in
lungs and the subsequent spread to distant body sites.
TLR2 KO Mice Demonstrate Reduced Lung Inflammation
To obtain further insight into the involvement of TLR2 and
TLR4 in the inﬂammatory response after infection with B.
pseudomallei, we semiquantitatively scored lung histology slides
generated from WT, TLR2 KO, and TLR4 KO mice at various
time points after infection. Infection of WT mice with B.
pseudomallei was characterized by severe pulmonary inﬂam-
mation, with abscess formation, necrosis, endothelialitis, and
thrombus formation. Consistent with the observed reduced
bacterial outgrowth, TLR2 KO mice displayed reduced organ
inﬂammation at 72 h postinfection when compared with WT
mice (Figure 5). Accordingly, the number of neutrophils
present in the lung, as analyzed by Gr1-immunostaining, was
lower in the TLR2 KO mice (insets, Figure 5A–5F). As
expected, TLR2 KO mice that survived the 6 wk survival study
described above showed decreased lung inﬂammation as
compared to the 72 h time point; the abscesses that were still
present were encapsulated in these animals (Figure 5H). In
contrast with the TLR2 KO mice, the TLR4 KO mice showed
similar inﬂammation compared with WT mice (unpublished
data).
Diminished Late Proinflammatory Cytokine and Increased
Early Anti-inflammatory Cytokine Production in TLR2 KO
Mice
The success of combating infections in the lung strongly
depends on the efﬁcacy of the local inﬂammatory response
elicited [29,30]. In order to study the extent and kinetics of
the inﬂammatory response, we sacriﬁced WT, TLR2 KO, and
TLR4 KO mice at multiple time points after infection and
measured the concentrations of the proinﬂammatory cyto-
kines TNFa and IL6 and the anti-inﬂammatory cytokine IL10
in lung homogenates (Figure 6). TNFa and IL6 levels were
lower in TLR2 KO mice than in WT mice, especially at 72 h
after infection (p , 0.05 and p , 0.001, respectively). In
addition, lung IL10 concentrations were moderately lower in
TLR2 KO mice at 24 and 48 h after infection (p , 0.05). In
contrast, the pulmonary levels of these mediators were similar
in TLR4 KO and WT mice at all time points. In addition,
TLR2 deﬁciency did not inﬂuence the expression of TLR4 on
lung macrophages or blood monocytes or granulocytes
throughout the infection (Figure 7).
TLR2 KO Mice, but Not TLR4 KO Mice, Demonstrate
Decreased Distant Organ Injury
To further evaluate the role of TLR2 and TLR4 in the
systemic inﬂammatory response after infection with B.
pseudomallei, we semiquantitatively scored spleen histology
slides generated from infected mice and performed routine
clinical chemistry to evaluate hepatic and renal injury. No
differences were observed between WT and TLR4 KO mice at
any time point (unpublished data). However, TLR2 KO
showed diminished inﬂammation in their spleens when
compared to the WT mice (Figure 8A–8C). Furthermore,
liver and kidney function were relatively well preserved in
TLR2 KO mice, as reﬂected by lower ASAT, ALAT, blood
urea nitrogen (BUN), and creatinine plasma levels in these
animals (Figure 8D–8G).
Discussion
In the present study we aimed to characterize the
expression and function of the TLRs in septic melioidosis,
linking observational studies in patients with culture-proven
disease with functional studies in TLR-deﬁcient mice. We
Figure 3. Survival of TLR2 KO Mice, but Not of TLR4 KO Mice, Is Enhanced during Experimental Melioidosis
(A) Survival after intranasal inoculation with B. pseudomallei in WT (open circles), TLR2 KO mice (closed squares) and (B) TLR4 KO mice (closed squares).
Mortality was assessed twice daily for 6 wk. n ¼ 12 per group. p-Value indicates the difference between TLR2 KO and WT mice. ns, not significant.
doi:10.1371/journal.pmed.0040248.g003
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TLRs in Melioidosismade the following key observations. (1) Patients with septic
melioidosis have increased expression of CD14, TLR1, TLR2,
and TLR4 on the cell surfaces of circulating monocytes and
granulocytes and increased levels of mRNAs encoding CD14,
LY96, TLR1, TLR2, TLR3, TLR4, TLR5, TLR8, and TLR10 in
peripheral blood cells. (2) Both TLR2 and TLR4 contribute to
cellular responsiveness to Burkholderia in vitro, as reﬂected by
reduced TNFa release by alveolar macrophages and whole
blood from TLR2 KO and TLR4 KO mice and by activation of
HEK293 cells stably transfected with either TLR2 or TLR4
upon incubation with B. pseudomallei. (3) The LPS of B.
pseudomallei signals through TLR2 and not through TLR4. And
(4) TLR4 is not important for protective immunity against
experimentally induced melioidosis, whereas TLR2 is asso-
ciated with the growth and dissemination of the infection,
signiﬁcantly contributing to distant organ injury and lethal-
ity.
Our study is, to our knowledge, the ﬁrst to provide insights
into the relative gene expression of all TLR family members
in peripheral blood monocytes and granulocytes in patients
with severe sepsis. In blood samples obtained from 34
prospectively enrolled patients with sepsis caused by B.
pseudomallei, we showed that a whole repertoire of TLRs is
up-regulated at the mRNA level in both monocytes and
granulocytes. Of note, patients showed enhanced monocyte
and granulocyte expression of three of four TLR4 splice
variants. TLR4 variant R02 remained undetectable, which is
consistent with our earlier study examining alveolar macro-
phages from healthy humans challenged with LPS via the
airways [15]. TLR4 variant R01 is involved in LPS binding and
triggering of intracellular signal transduction cascades, while
variants R03 and R04 lack residues 24–34, which are essential
for LY96 (MD2) binding and LPS signaling [31]. The
expression of TLR3 mRNA was very low in both patients
and healthy controls, which can be explained by the fact that
this intracellular receptor is primarily expressed by dendritic
cells and to a lesser extent B and T cells [32–34]. In addition,
we could not detect TLR9 mRNA in monocytes or granulo-
cytes, which is in line with studies showing that TLR9 mRNA
in particular is expressed in plasmacytoid dendritic cells and
B cells. The increase in mRNAs encoding CD14, TLR1, TLR2,
and TLR4 was accompanied by enhanced surface expression
o ft h er e s p e c t i v ep r o t e i n sc irculating neutrophils and
granulocytes. This is in accordance with two earlier clinical
reports, which found increased expression of TLR2 and TLR4
on neutrophils and monocytes from septic patients [35,36].
Humans usually acquire melioidosis by inoculation
through skin abrasions or inhalation [3,4]. Pneumonia with
bacterial dissemination to distant body sites is a common
presentation of melioidosis [5]. We decided to develop a
Figure 4. Bacterial Loads in Lungs, Spleen, and Blood
TLR2 KO mice demonstrate strongly reduced bacterial loads at 72 h after infection in lungs (A), spleen (B), and blood (C). TLR4 KO mice showed a
modestly enhanced outgrowth at 24 h after infection in spleen (E) and blood (F) but not in lungs (D). Data are mean 6 SEM (n¼8 per group) at 24, 48,
and 72 h after inoculation with B. pseudomallei in WT mice (open bars), TLR2 KO mice (black bars), and TLR4 KO mice (crosshatched bars). *p , 0.05; ***p
, 0.0001. ns, not significant.
doi:10.1371/journal.pmed.0040248.g004
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TLRs in Melioidosismouse model in which B. pseudomallei was administered via the
airways, since this route may be more clinically relevant than
the intraperitoneal route used in several previous studies. We
reproduced the major clinical characteristics of melioidosis,
with rapid spread of bacteria to distant organs, multiple
organ failure and abscess formation. Among the TLRs with
enhanced expression in patients with melioidosis, we consid-
ered TLR2 and TLR4 most interesting with respect to the
impact of their loss of function in experimentally induced
melioidosis in mice. Indeed, of the other TLRs that showed
increased expression, TLR1 has been implicated as a co-
receptor together with TLR2 in the recognition of bacterial
triacyl lipopeptides, whereas TLR8 senses single-stranded
viral RNA [1,2]. In addition, although TLR5, as the receptor
that recognizes ﬂagellin, in theory may be involved in host
defense against B. pseudomallei, a recent report suggests that
TLR5 especially or exclusively senses pathogenic ﬂagellated
bacteria present in the intestinal lumen, whereas the
expression of this receptor was low in the mouse lung [37].
A remarkable and unexpected ﬁnding was that, although
TLR4 appeared very important for cellular responsiveness to
B. pseudomallei in vitro (Figure 2), this receptor does not
signiﬁcantly contribute to host defense against melioidosis in
vivo. In line with these in vivo observations, we demonstrated
that puriﬁed LPS from B. pseudomallei 1026b (the strain also
used in the in vivo infection studies) activates HEK293 cells
via TLR2, not via TLR4. The evidence that TLR4 has an
important role in gram-negative infections is exclusively
derived from models using bacteria that express LPS
recognized by TLR4 [9]. Indeed, TLR4-deﬁcient mice are
more susceptible to gram-negative sepsis due to Salmonella
typhimurium and Escherichia coli and to gram-negative pneumo-
nia due to Haemophilus inﬂuenzae, Klebsiella pneumoniae, and
Acinetobacter baumannii [27,38–41]. Of note, B. pseudomallei LPS
differs in several aspects from the LPS of other gram-negative
organisms: B. pseudomallei LPS exhibits weaker pyrogenic
activity in rodents compared with enterobacterial LPS [4,42],
and LPS-mediated activation of mouse macrophages in vitro
is slower for LPS from B. pseudomallei than for E. coli LPS [43].
In this respect it is of interest that our laboratory previously
Figure 5. Reduced Lung Inflammation in TLR2 KO Mice 72 Hours after Infection
Representative lung histology of WT (A, C, and E) and TLR2 KO mice (B, D, and F) at 24 h (A and B), 48 h (C and D), and 72 h (E and F) after inoculation
with 5 3 10
2 CFU B. pseudomallei. TLR2 KO showed significantly less inflammation, pleuritis, peribronchial inflammation, edema, endothelialitis, and
necrosis 72 h after infection in the mice (F and G) compared to WT (E–G). Pathology scores (mean 6 SEM) (G) were calculated as described in the
Methods section; open bars represent WT mice, and solid bars represent the TLR2 KO mice. The insets (A–F) are representative images of
immunostaining for granulocytes, showing dense granulocytic infiltrations and confirming reduced inflammation and granulocyte influx in the TLR2K O
mice at 72 h after inoculation with B. pseudomallei. TLR2 KO mice that survived the experiment shown in Figure 3A were examined 6 wk after
inoculation; as expected, they showed decreased organ inflammation as compared to the 72 h time point The abscesses that were still present were
encapsulated (H). Magnification, 203. All data are from eight mice per group at each time point, except for (H) (n ¼ 5).
doi:10.1371/journal.pmed.0040248.g005
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TLRs in Melioidosisestablished that TLR4 is not involved in host defense against
pulmonary infection with Legionella pneumophila [44], a gram-
negative bacterium of which the LPS, like B. pseudomallei LPS,
is a weak inducer of proinﬂammatory cytokine production by
mononuclear cells [45]. Hence, it is conceivable that absent or
insufﬁcient LPS sensing by TLR4 makes this receptor
redundant during infection in vivo with Legionella or
Burkholderia. In addition, the recent ﬁnding that TLR4 does
Figure 6. TLR2 KO Mice, but Not TLR4 KO Mice, Show Reduced Pulmonary Cytokine Levels during Experimental Melioidosis
WT mice (open symbols) (A–F), TLR2 KO mice (closed symbols) (A, C, and E), and TLR4 KO mice (closed symbols) (B, D, and F) were intranasally infected
with 5310
2 CFU of B. pseudomallei. 24, 48, and 72 h after inoculation mice were sacrificed, lungs were removed, and TNFa (A and B), IL6 (C and D), and
IL10 (E and F) were measured in lung homogenates. Data are means 6 SEM of eight mice per group per time point. *p , 0.05; **p , 0.001; ***p ,
0.0001.
doi:10.1371/journal.pmed.0040248.g006
Figure 7. No Difference in TLR4 Expression in TLR2 KO Mice Compared to WT Mice during Infection with B. pseudomallei
TLR4 cell surface expression is depicted over time (0, 24, 48, and 72 h after intranasal inoculation with B. pseudomallei), on the lung macrophages (A),
blood monocytes (B), and blood granulocytes (C). Data are expressed as mean 6 SEM and n ¼ 4 mice per group at each time point. MFI, mean
fluorescence intensity.
doi:10.1371/journal.pmed.0040248.g007
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TLRs in Melioidosisnot mediate resistance against acute lung infection due to
Pseudomonas aeruginosa suggests that for some gram-negative
pathogens signaling to other pattern recognition receptors
may compensate for the loss of LPS–TLR4 signaling [46].
TLR2 is a promiscuous pattern recognition receptor
recognizing multiple ligands expressed by a variety of
microorganisms such as Mycoplasma (diacyl lipopeptides),
mycobacteria (triacyl lipopeptides, lipoarabinomannan), fun-
gi (zymosan, phospholipomannan), parasites (tGPI-mutin),
and viruses (hemagglutinin protein from measles virus and
unidentiﬁed structures of herpes simplex virus) [1,2]. In
addition, TLR2 can signal a number of PAMPs expressed by
bacteria, in particular lipoteichoic acid (exclusively expressed
by gram-positive bacteria), peptidoglycan and triacyl lip-
opeptides (found in most bacteria), and porins (Neisseria) [1,2].
Finally, TLR2 may be activated by LPS from some gram-
negative bacteria [47–49]. We here found that TLR2 contrib-
utes to the responsiveness of cells to B. pseudomallei using two
complementary approaches: TLR2 KO macrophages and
blood produced less TNFa upon stimulation with Burkholderia,
whereas TLR2 transfected HEK293 cells released large
amounts of IL8 upon incubation with this bacterium. In
addition, we identiﬁed B. pseudomallei LPS as a TLR2 ligand.
Conceivably, B. pseudomallei expresses more TLR2 ligands,
with peptidoglycan and lipopeptides being possible candi-
dates. The interaction between Burkholderia and TLR2 clearly
impairs the protective immune response against this bacte-
rium, as reﬂected by the fact that TLR2 KO mice displayed a
strongly reduced mortality during experimental melioidosis,
which was associated with a diminished bacterial growth and
dissemination, and reduced distant organ injury. Previously,
TLR2 KO mice were found to be less susceptible to lethal
infections with Yersinia enterocolitica or Candida albicans
through a mechanism that likely involved a stronger type 1
cytokine response due to diminished production of the
prototypic type 2 cytokine IL10 during infection [50,51]. In
the case of Candida infection, TLR2 induced proliferation and
survival of regulatory T cells, which appeared largely
responsible for the increased IL10 release induced by TLR2
[51]. Although a type 1 response is protective in melioidosis
[52,53], a loss of type 2 cytokine stimulation in TLR2 KO mice
cannot explain the protection of these animals during B.
pseudomallei infection. First, the differences in IL10 concen-
trations between TLR2 KO and WT mice were minor and
much less profound than the concurrent differences in the
proinﬂammatory cytokine TNFa. Second, the concentrations
of the prototypic type 1 cytokine interferon gamma remained
very low or undetectable throughout the entire observation
period (unpublished data). Finally, antibody-mediated deple-
tion of regulatory T cells did not inﬂuence the outcome of
melioidosis in our model (unpublished data). More studies are
warranted to dissect the exact mechanism by which TLR2
facilitates the growth and spread of B. pseudomallei in vivo.
Melioidosis is a debilitating disease with an unacceptably
high mortality rate [3,4]. We here demonstrate that the
expression of multiple TLRs is up-regulated in peripheral
blood leukocytes in septic patients with melioidosis. Most
remarkable, although our results show that both TLR2 and
Figure 8. TLR2 KO Mice Demonstrate Reduced Distant Organ Injury
Mice were intranasally inoculated with 5 3 10
2 CFU of B. pseudomallei. After 72 h, representative spleen histology of WT (A) and TLR2 KO (B) mice
demonstrated decreased inflammation and less thrombus formation in the TLR2 KO spleens. Magnification, 12.53. Arrows indicate increased thrombus
formation in the WT mice compared to TLR2 KO mice. The reduced inflammation and injury in the spleen at 72 h after infection (C) was confirmed by
the semiquantitative pathology score described in the Methods. At this time point TLR2 KO mice also showed less hepatic injury, as reflected by the
plasma concentrations of ASAT (D) and ALAT (E), and less renal failure, as reflected by plasma creatinine (F) and blood urea nitrogen (BUN) (G). Data are
expressed as mean 6 SEM of eight WT mice (open bars) and eight TLR2 KO mice (black bars). *p , 0.05; **p , 0.01 versus WT control.
doi:10.1371/journal.pmed.0040248.g008
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TLRs in MelioidosisTLR4 contribute to cellular responsiveness to B. pseudomallei
in vitro, TLR2 detects the LPS of B. pseudomallei and only
TLR2 impacts on the immune response of the intact host in
vivo. Of note, TLR4 does not contribute to protective
immunity in this severe gram-negative infection. Taken
together, these ﬁndings suggest that septic melioidosis can
be seen as the clinical manifestation of a TLR-mediated
dysregulation of the immune response to invasive B.
pseudomallei. In addition, this report further undermines the
paradigm regarding TLR4 as ‘‘the gram-negative receptor’’
and TLR2 as ‘‘the gram-positive receptor.’’ Inhibition of
TLR2 may be a useful adjunctive therapy for melioidosis.
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Editors’ Summary
Background. Melioidosis is a severe tropical infection caused by the
bacterium Burkholderia pseudomallei. This soil-dwelling pathogen (dis-
ease-causing organism) enters the body through cuts, by swallowed
contaminated water, or by inhaled contaminated dust. Here, it can cause
a severe lung infection or spread into the blood stream and around the
body, where it causes widespread inflammation (sepsis) and organ
failure. Untreated septic melioidosis is usually fatal. Even with antibiotic
therapy, half the people who develop it in Thailand (a hot spot for
melioidosis) die. B. pseudomallei is a ‘‘gram-negative’’ bacterium. That is,
it is surrounded by a membrane that stops it taking up a stain used to
detect bacteria. This membrane contains a molecule called lipopolysac-
charide (LPS). Proteins on immune system cells called Toll-like receptors
(TLRs), of which there are many, recognize LPS and other surface
molecules common to different pathogens and tell the cells to make
cytokines. These cytokines stimulate the immune system to kill the
pathogen but also cause inflammation, the underlying problem in septic
melioidosis and other forms of sepsis. In other words, TLRs are two-
edged swords—they provide an essential first-line defense against
pathogens, but cause life-threatening inflammation if overstimulated.
Why Was This Study Done? It isn’t known which TLRs are involved in
melioidosis. TLR4 normally detects LPS, but the surface of B. pseudomallei
also carries molecules that interact with TLR2. Understanding how B.
pseudomallei interacts with TLRs might suggest new, more effective ways
to treat septic melioidosis. Better remedies for this disease are badly
needed because, as well as the infections it causes in the community, the
US Centers for Disease Control and Prevention has identified B.
pseudomallei as a potential bioterrorism agent. In this study, the
researchers have characterized the expression and function of TLRs in
septic melioidosis using human, in vitro (test tube), and animal
approaches.
What Did the Researchers Do and Find? The researchers isolated
monocytes and granulocytes (immune system cells involved in first-line
defenses against pathogens) from patients with melioidosis and from
healthy people. The patients’ cells made more TLR1, TLR2, TLR4, and
CD14 (a protein that enhances the activation of immune system cells by
LPS) than those of the healthy controls and more of the mRNAs
encoding several other TLRs. Next, the researchers tested the ability of
heat-killed B. pseudomallei to induce the release of TNFa (a cytokine
produced in response to TLR signaling) from macrophages (immune
system cells that swallow up pathogens) isolated from wild-type mice
and from mice lacking TLR2 or TLR4. Macrophages isolated from wild-
type mice made more TNFa than those from TLR2- or TLR4-deficient
mice. In addition, a human kidney cell line engineered to express CD14/
TLR2 or CD14/TLR4 but not the parent cell line released IL8 (another
cytokine) when stimulated with heat-killed B. pseudomallei. Other
experiments in these human cell lines showed that LPS purified from
B. pseudomallei signals through TLR2 but not through TLR4. Finally, the
researchers tested the ability of TLR2- and TLR4-deficient mice to survive
after infection with live B. pseudomallei. Compared with TLR4-deficient or
wild-type mice, the TLR2-deficient mice had a strong survival advantage,
a lower bacterial load, reduced lung inflammation, and less organ
damage.
What Do These Findings Mean? These findings show that people with
melioidosis have increased expression of several TLRs, any one of which
might cause the sepsis associated with B. pseudomallei infection. The in
vitro findings indicate that TLR2 and TLR4 both contribute to the
responsiveness of immune cells to B. pseudomallei in test tubes, but that
only TLR2 detects the LPS of this bacterium. This unexpected result—
TLR4 normally responds to LPS—might indicate that there is something
unique about the LPS of B. pseudomallei. Finally, the survival of TLR2-
deficient mice after infection with B. pseudomallei suggests that TLR2-
mediated dysregulation of the immune system in response to invasive B.
pseudomallei might cause septic melioidosis. Although these results
need confirming in people, they suggest that inhibition of TLR2 in
combination with antibiotic therapy might improve outcomes for people
with melioidosis.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0040248.
  Information is available from the US Centers for Disease Control and
Prevention on melioidosis (in English and Spanish)
  The UK Health Protection Agency provides information for the public
and health professionals on melioidosis
  Wikipedia has pages on melioidosis and on Toll-like receptors (note:
Wikipedia is a free online encyclopedia that anyone can edit; available
in several languages)
  The MedlinePlus encyclopedia contains a page on sepsis (in English
and Spanish)
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